These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38708901)

  • 1. Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas9.
    Mahmood M; Taufiq I; Mazhar S; Hafeez F; Malik K; Afzal S
    Per Med; 2024; 21(3):175-190. PubMed ID: 38708901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.
    Selvakumar SC; Preethi KA; Ross K; Tusubira D; Khan MWA; Mani P; Rao TN; Sekar D
    Mol Cancer; 2022 Mar; 21(1):83. PubMed ID: 35331236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment.
    Xing H; Meng LH
    Acta Pharmacol Sin; 2020 May; 41(5):583-587. PubMed ID: 31792341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9-Edited Site Sequencing (CRES-Seq): An Efficient and High-Throughput Method for the Selection of CRISPR-Cas9-Edited Clones.
    Veeranagouda Y; Debono-Lagneaux D; Fournet H; Thill G; Didier M
    Curr Protoc Mol Biol; 2018 Jan; 121():31.14.1-31.14.11. PubMed ID: 29337372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the evolving CRISPR/Cas9 for precision oncology.
    Li T; Li S; Kang Y; Zhou J; Yi M
    J Transl Med; 2024 Aug; 22(1):749. PubMed ID: 39118151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of CRISPR/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells.
    Park SH; Lee CM; Bao G
    Methods Mol Biol; 2022; 2429():281-306. PubMed ID: 35507169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond.
    Mirza Z; Karim S
    Semin Cell Dev Biol; 2019 Dec; 96():13-21. PubMed ID: 31150758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR cures and cancer vaccines: researchers can help to shepherd them to market.
    Nature; 2024 Jun; 630(8016):269. PubMed ID: 38867131
    [No Abstract]   [Full Text] [Related]  

  • 9. BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment.
    Boel A; Steyaert W; De Rocker N; Menten B; Callewaert B; De Paepe A; Coucke P; Willaert A
    Sci Rep; 2016 Jul; 6():30330. PubMed ID: 27461955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR cancer trial success paves the way for personalized treatments.
    Ledford H
    Nature; 2022 Nov; 611(7936):433-434. PubMed ID: 36357583
    [No Abstract]   [Full Text] [Related]  

  • 12. A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.
    Huang W; Zeng ZC; Wang WT; Sun YM; Chen YQ; Luo XQ; Fang K
    Clin Transl Med; 2021 Mar; 11(3):e355. PubMed ID: 33783997
    [No Abstract]   [Full Text] [Related]  

  • 13. CRISPR-Cas9 Targeted Enrichment and Next-Generation Sequencing for Mutation Detection.
    Malekshoar M; Azimi SA; Kaki A; Mousazadeh L; Motaei J; Vatankhah M
    J Mol Diagn; 2023 May; 25(5):249-262. PubMed ID: 36841425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large-scale whole-genome sequencing analysis reveals highly specific genome editing by both Cas9 and Cpf1 (Cas12a) nucleases in rice.
    Tang X; Liu G; Zhou J; Ren Q; You Q; Tian L; Xin X; Zhong Z; Liu B; Zheng X; Zhang D; Malzahn A; Gong Z; Qi Y; Zhang T; Zhang Y
    Genome Biol; 2018 Jul; 19(1):84. PubMed ID: 29973285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BATCH-GE: Analysis of NGS Data for Genome Editing Assessment.
    Steyaert W; Boel A; Coucke P; Willaert A
    Methods Mol Biol; 2018; 1865():83-90. PubMed ID: 30151760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revolutionizing Lung Cancer Treatment: Innovative CRISPR-Cas9 Delivery Strategies.
    Singh D
    AAPS PharmSciTech; 2024 Jun; 25(5):129. PubMed ID: 38844700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
    Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
    Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
    Jiang C; Meng L; Yang B; Luo X
    Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput screening strategy for detecting CRISPR-Cas9 induced mutations using next-generation sequencing.
    Bell CC; Magor GW; Gillinder KR; Perkins AC
    BMC Genomics; 2014 Nov; 15(1):1002. PubMed ID: 25409780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.